| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Radiation Research [S. U., T. O.], Neurosurgery [T. K., T. Y.], and Forensic Medicine [Y. A., M. N., K. S.], Tohoku University School of Medicine, 2-1 Seiryomachi, Aoba-ku, Sendai 980-77, Japan
Genomic imprinting is a gamete-specific modification resulting in the allele-specific expression of genes in somatic cells. A loss of imprinting (LOI) has been found in many embryonal and adult tumors, suggesting that it plays a role in tumor development. The incidence of LOI, however, does not seem to be ubiquitous among tumors because neuroblastoma and colorectal cancer revealed no LOI. We examined the involvement of LOI of IGF2 and H19 genes in human gliomas. The two genes were imprinted in normal brain subcortex tissues. In glioma, 8 of 14 informative cases (57%) revealed LOI in IGF2. The frequency did not depend on the tumor grade. For H19, in contrast, all 13 informative cases maintained imprinting. These results suggest that LOI of IGF2 but not H19 plays a role in the development of human glioma.
1 Supported in part by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture and the Ministry of Health and Welfare of Japan.
2 To whom requests for reprints should be addressed. Phone: 81-22-717-8132; Fax: 81-22-717-8136.
Received 8/23/96. Accepted 10/17/96.
This article has been cited by other articles:
![]() |
L. Soroceanu, S. Kharbanda, R. Chen, R. H. Soriano, K. Aldape, A. Misra, J. Zha, W. F. Forrest, J. M. Nigro, Z. Modrusan, et al. Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma PNAS, February 27, 2007; 104(9): 3466 - 3471. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Zumkeller and M Westphal The IGF/IGFBP system in CNS malignancy Mol. Pathol., August 1, 2001; 54(4): 227 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Muller, D. van den Boom, D. Zirkel, H. Koster, F. Berthold, M. Schwab, M. Westphal, and W. Zumkeller Retention of imprinting of the human apoptosis-related gene TSSC3 in human brain tumors Hum. Mol. Genet., March 22, 2000; 9(5): 757 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Chen, S.-M. Ip, D. Cheng, L.-C. Wong, and H. Y. S. Ngan Loss of Imprinting of the IGF-II and H19 Genes in Epithelial Ovarian Cancer Clin. Cancer Res., February 1, 2000; 6(2): 474 - 479. [Abstract] [Full Text] |
||||
![]() |
J. G. Falls, D. J. Pulford, A. A. Wylie, and R. L. Jirtle Genomic Imprinting: Implications for Human Disease Am. J. Pathol., March 1, 1999; 154(3): 635 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Adriaenssens, L. Dumont, S. Lottin, D. Bolle, A. Lepretre, A. Delobelle, F. Bouali, T. Dugimont, J. Coll, and J.-J. Curgy H19 Overexpression in Breast Adenocarcinoma Stromal Cells Is Associated with Tumor Values and Steroid Receptor Status but Independent of p53 and Ki-67 Expression Am. J. Pathol., November 1, 1998; 153(5): 1597 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Paquette, N. Giannoukakis, C. Polychronakos, P. Vafiadis, and C. Deal The INS 5' Variable Number of Tandem Repeats Is Associated with IGF2 Expression in Humans J. Biol. Chem., June 5, 1998; 273(23): 14158 - 14164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |